|Bid||3.3600 x 0|
|Ask||3.4300 x 0|
|Day's Range||3.2800 - 3.7000|
|52 Week Range||1.4900 - 20.3500|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Canopy Growth’s chief executive officer expects the United States cannabis market to open up at the federal level as early as 2022 as pressure builds from state governments embracing recreational pot sales.
Despite recent troubles, Canopy Growth is optimistic its cannabis beverages can dwarf the growth of hard seltzers.
Shares of Canopy growth (CGC) are trading 30% lower since its latest quarterly results last week. However one analyst sees share as undervalued for the Canadian cannabis company which has shifted from medical to more recreational sales when that market was legalized in Canada almost two years ago. “Although we expect the medical market to shrink because of recreational legalization, we forecast more than 10% average annual growth for the entire Canadian market through 2030, driven by the conversion of black-market consumers into the legal market and new cannabis consumers,” analyst Kristoffer Inton wrote in a note to investors.
Canopy Growth has launched a new hemp-derived CBD line, its first consumer products targeting the massive American market.
The chief executives of Canopy Growth Corp. and Acreage Holdings Inc. are encouraged by growing support for cannabis reform in the United States, developments that could pave the way for Canopy becoming the largest player in the massive American market.
Members of the deal team at Canopy Rivers Inc. look at about seven investment opportunities per day, getting to know cannabis entrepreneurs eager for financial backing in a sector where the stigma of illegal drugs lingers.
Cannabis giant Canopy Growth Corp. reported a $1.28 billion net loss in its fiscal first quarter, a more than 1,300 per cent increase over the same period a year ago.
Former Canopy Growth Corp. co-CEO and chairman Bruce Linton is borrowing the strategy he used to build the world’s largest cannabis company.
The nascent marijuana industry has made significant strides over the past several years. But the once-illicit marijuana market still has hurdles to cross before unlocking its full potential, according to executives at some of the world’s leading cannabis companies.